CLL-1 targeted CAR-T therapy

CAR-T cell therapy targeting CLEC12A (CLL-1) · Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLL-1 targeted CAR-T therapy, covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen [Phase 1]